STRM Stock Forecast 2025-2026
Distance to STRM Price Targets
STRM Price Momentum
10 Quality Stocks Worth Considering Now
Researching Streamline Health (STRM) after the drop? Our ex-Goldman Sachs analyst reveals if it made our list of 10 oversold quality stocks with strong growth potential.
Get our FREE market selloff report + exclusive analysis on STRM and similar high-potential opportunities.
Latest STRM Stock Price Targets & Analyst Predictions
Based on our analysis of 3 Wall Street analysts, STRM has a bullish consensus with a median price target of $22.50 (ranging from $22.50 to $22.50). Currently trading at $3.24, the median forecast implies a 594.4% upside. This outlook is supported by 1 Buy, 0 Hold, and 0 Sell ratings.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
STRM Analyst Ratings
STRM Price Target Range
Latest STRM Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for STRM.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Nov 21, 2022 | Lake Street | Brooks O'Neil | Buy | Assumes | $3.00 |
| May 20, 2022 | Lake Street | Kyle Bauser | Buy | Initiates | $3.00 |
| Apr 25, 2016 | Lake Street | Hold | Downgrade | $0.00 | |
| Sep 4, 2015 | Cowen & Co. | Outperform | Maintains | $5.00 | |
| Feb 4, 2014 | Lake Street | Buy | Initiates | $0.00 | |
| Dec 3, 2013 | Avondale Partners | Market Outperform | Initiates | $0.00 |
Streamline Health Solutions Inc. (STRM) Competitors
The following stocks are similar to Streamline Health based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Streamline Health Solutions Inc. (STRM) Financial Data
Streamline Health Solutions Inc. has a market capitalization of $13.85M with a P/E ratio of -0.7x. The company generates $18.59M in trailing twelve-month revenue with a -50.5% profit margin.
Revenue growth is -0.7% quarter-over-quarter, while maintaining an operating margin of -71.4% and return on equity of -55.8%.
Valuation Metrics
Growth & Margins
Financial Health
Get All 10 Quality Stocks For This Market Selloff
Still researching investments after the market drop? Our ex-Goldman Sachs analyst has already identified the 10 highest-quality oversold stocks with strong fundamentals and upside potential.
Why spend hours researching when we've already done the work? Get instant access to our complete market selloff analysis.
Streamline Health Solutions Inc. (STRM) Business Model
About Streamline Health Solutions Inc.
Provides software solutions for healthcare efficiency.
The company generates revenue by offering software solutions focused on analytics, revenue cycle management, and business intelligence to healthcare providers. By optimizing operational efficiency and helping clients manage clinical data effectively, they charge for their technology and support services, ensuring compliance with healthcare regulations.
Streamline Health Solutions plays a vital role in enhancing patient care, billing accuracy, and financial recovery in healthcare settings such as hospitals and clinics. Their advanced data analytics capabilities are integral to improving decision-making and overall performance in healthcare operations.
Company Information
Sector
Healthcare
Industry
Health Information Services
Employees
77
CEO
Mr. Benjamin L. Stilwill
Country
United States
IPO Year
1996
Website
www.streamlinehealth.netStreamline Health Solutions Inc. (STRM) Latest News & Analysis
Streamline Health® Announces Fourth CommunityWorks RevID Contract With Kentucky-Based Health System
2 months agoOracle Health partners with a Kentucky-based 120-bed health system to implement RevID's automated charge reconciliation, aiming to enhance financial performance.
The partnership enhances operational efficiency and financial performance for healthcare systems, potentially leading to increased profitability and attractiveness for investors in Oracle Health.
A 1,200-bed health system has chosen eValutor's pre-bill code audit technology to enhance coding accuracy, potentially improving operational efficiency.
The adoption of eValutor's technology by a large health system signals a focus on operational efficiency and cost management, potentially boosting profitability and investor confidence in healthcare stocks.
Streamline Health Solutions, Inc. (NASDAQ: STRM) will host its Q3 2024 earnings conference call on December 17, 2024, at 9:00 AM ET, featuring key executives.
The Q3 2024 earnings call for Streamline Health Solutions on December 17 will provide crucial insights into the company’s financial performance and future outlook, influencing investment decisions.
Oracle Health partners with a Texas-based 400-bed health system to implement RevID's automated charge reconciliation, aimed at enhancing financial performance.
The Oracle Health partnership enhances revenue management for the Texas health system, likely boosting its profitability and operational efficiency, which could positively impact Oracle's stock performance.
Streamline Health Solutions, Inc. (Nasdaq: STRM) reported its Q3 fiscal 2024 financial results for the period ending October 31, 2024, focusing on healthcare revenue management solutions.
Streamline Health Solutions' Q3 financial results indicate its performance and growth potential, impacting investor sentiment and stock valuation in the healthcare sector.
Streamline Health Solutions (Nasdaq: STRM) will release its financial results for Q4 2024 on December 16, 2024, after market close.
Streamline Health Solutions' upcoming financial results may impact stock performance, reflecting its ability to manage revenue and financial health in the healthcare sector.
Frequently Asked Questions About STRM Stock
What is Streamline Health Solutions Inc.'s (STRM) stock forecast for 2025?
Based on our analysis of 3 Wall Street analysts, Streamline Health Solutions Inc. (STRM) has a median price target of $22.50. The highest price target is $22.50 and the lowest is $22.50.
Is STRM stock a good investment in 2025?
According to current analyst ratings, STRM has 1 Buy ratings, 0 Hold ratings, and 0 Sell ratings. The stock is currently trading at $3.24. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for STRM stock?
Wall Street analysts predict STRM stock could reach $22.50 in the next 12 months. This represents a 594.4% increase from the current price of $3.24. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Streamline Health Solutions Inc.'s business model?
The company generates revenue by offering software solutions focused on analytics, revenue cycle management, and business intelligence to healthcare providers. By optimizing operational efficiency and helping clients manage clinical data effectively, they charge for their technology and support services, ensuring compliance with healthcare regulations.
What is the highest forecasted price for STRM Streamline Health Solutions Inc.?
The highest price target for STRM is $22.50 from at , which represents a 594.4% increase from the current price of $3.24.
What is the lowest forecasted price for STRM Streamline Health Solutions Inc.?
The lowest price target for STRM is $22.50 from at , which represents a 594.4% increase from the current price of $3.24.
What is the overall STRM consensus from analysts for Streamline Health Solutions Inc.?
The overall analyst consensus for STRM is bullish. Out of 3 Wall Street analysts, 1 rate it as Buy, 0 as Hold, and 0 as Sell, with a median price target of $22.50.
How accurate are STRM stock price projections?
Stock price projections, including those for Streamline Health Solutions Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
